top of page


Submissions must clearly indicate the following:


  • Title – Limit 25 words using sentence case (i.e., capitalize the first word while the remaining words begin in lowercase). Provide a succinct title that should ideally contain a reference to the study design.

  • Authors / Affiliations

  • Abstract Body

  1. Length 250 words (not including title, authors and affiliations or keywords) written in single space

  2. Tables and figures are not permitted

  3. Format – Objectives: / Design and Methods: / Results: / Conclusions:

  • Keywords – maximum of 5

  • Funding Acknowledgement – if required

  • Granting Agency and Number – e.g., Ontario Neurotrauma Foundation 2012-017



Please also note the following submission guidelines:

  1. Writing must be concise, clear, and grammatically correct.

  2. Technical information pertaining to observations and conclusions cannot be withheld for proprietary reasons. It is not acceptable to state that “results will be discussed”.

  3. Special characters should instead be written out (e.g., micromol/L instead of μmol/L).

  4. All abbreviations should be defined when first used.

  5. If used, references should be given in parentheses without authors or title by provided Index-Medicus-listed Journal abbreviations without punctuation followed by the year, volume number and inclusive page numbers (e.g., Clin Biochem 2002;35:151-169).

  6. All presenting authors must register for the conference and pay the registration fees to be selected for the presentation.

  7. Five abstracts for oral presentation will be selected.

Please submit abstracts online by March 31, 2023, for consideration.

bottom of page